These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8481901)
1. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma. Epner DE; Partin AW; Schalken JA; Isaacs JT; Coffey DS Cancer Res; 1993 May; 53(9):1995-7. PubMed ID: 8481901 [TBL] [Abstract][Full Text] [Related]
2. There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue. Epner DE; Coffey DS Prostate; 1996 Jun; 28(6):372-8. PubMed ID: 8650074 [TBL] [Abstract][Full Text] [Related]
3. Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model. Mohler JL; Partin AW; Isaacs JT; Coffey DS Cancer Res; 1988 Aug; 48(15):4312-7. PubMed ID: 3390827 [TBL] [Abstract][Full Text] [Related]
4. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model. Mohler JL; Levy F; Sharief Y Cancer Res; 1991 Dec; 51(24):6580-5. PubMed ID: 1742730 [TBL] [Abstract][Full Text] [Related]
5. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma. Schek N; Hall BL; Finn OJ Cancer Res; 1988 Nov; 48(22):6354-9. PubMed ID: 3180054 [TBL] [Abstract][Full Text] [Related]
6. The effect of castanospermine on the metastatic properties of prostate cancer cells. Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219 [TBL] [Abstract][Full Text] [Related]
7. Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model. Lowe FC; Isaacs JT Cancer Res; 1984 Feb; 44(2):744-52. PubMed ID: 6537899 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors. Powell CT; Fair WR; Heston WD Cell Growth Differ; 1994 Feb; 5(2):143-9. PubMed ID: 8180127 [TBL] [Abstract][Full Text] [Related]
10. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human cervical cancers. Kim JW; Kim SJ; Han SM; Paik SY; Hur SY; Kim YW; Lee JM; Namkoong SE Gynecol Oncol; 1998 Nov; 71(2):266-9. PubMed ID: 9826470 [TBL] [Abstract][Full Text] [Related]
11. Alteration of glyceraldehyde-3-phosphate dehydrogenase activity and messenger RNA content by androgen in human prostate carcinoma cells. Ripple MO; Wilding G Cancer Res; 1995 Oct; 55(19):4234-6. PubMed ID: 7671226 [TBL] [Abstract][Full Text] [Related]
12. Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for northern blot analysis of cell lines of varying malignant potential. Bhatia P; Taylor WR; Greenberg AH; Wright JA Anal Biochem; 1994 Jan; 216(1):223-6. PubMed ID: 8135355 [TBL] [Abstract][Full Text] [Related]
13. Cytoskeletal organization and cell motility correlates with metastatic potential and state of differentiation in prostate cancer. Donald CD; Cooper CR; Harris-Hooker S; Emmett N; Scanlon M; Cooke DB Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1033-8. PubMed ID: 11785653 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225 [TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF. Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244 [TBL] [Abstract][Full Text] [Related]
16. Anti-metastatic activities of all-trans retinoic acid, indole-3-carbinol and (+)-catechin in Dunning rat invasive prostate adenocarcinoma cells. Nwankwo JO Anticancer Res; 2002; 22(6C):4129-35. PubMed ID: 12553043 [TBL] [Abstract][Full Text] [Related]
17. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue. Jung M; Römer A; Keyszer G; Lein M; Kristiansen G; Schnorr D; Loening SA; Jung K Prostate; 2003 May; 55(2):89-98. PubMed ID: 12661033 [TBL] [Abstract][Full Text] [Related]
18. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Salnikow K; Costa M; Figg WD; Blagosklonny MV Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752 [TBL] [Abstract][Full Text] [Related]
19. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Gao AC; Lou W; Dong JT; Isaacs JT Cancer Res; 1997 Mar; 57(5):846-9. PubMed ID: 9041184 [TBL] [Abstract][Full Text] [Related]
20. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines. Tieva A; Bergh A; Damber JE Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]